Graft versus host disease following blood transfusion during coronary artery bypass grafting.

@article{Shamsi1998GraftVH,
  title={Graft versus host disease following blood transfusion during coronary artery bypass grafting.},
  author={Tahir Sultan Shamsi and Muhammad Shafi Rehman and Javed Kazi and Serajuddaula Syed},
  journal={JPMA. The Journal of the Pakistan Medical Association},
  year={1998},
  volume={48 9},
  pages={
          279-81
        }
}
Transfusion associated graft versus host disease (TA-GVHD) is an uncommon but fatal complication of blood transuflon and is characterised by fever, skin rash, bone marrow hypoplasia, liver impairment and diarrhoea. Typically, it develops 7-14 days following blood transfusion in an immunocompromised recipient but occasionally it has been reported in immuno-competent patients. The development of TA-GVI-ID depends upon the number of viable T lymphocytes transfused from the donor to the recipient… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 14 REFERENCES

Successful treatment of transfusion associated graft versus host disease

M Yasukawa, F Shinozak, T Hato
  • Br. J. Haematol.,
  • 1994

Similar Papers

Loading similar papers…